Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_assertion type Assertion NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_head.
- NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_assertion description "[CFCS is genetically heterogeneous and mutations in the KRAS, BRAF, MAP2K1 (MEK1) and MAP2K2 (MEK2) genes, encoding for components of the RAS-mitogen activated protein kinase (MAPK) signaling pathway, have been identified in up to 90% of cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_provenance.
- NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_assertion evidence source_evidence_literature NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_provenance.
- NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_assertion SIO_000772 19156172 NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_provenance.
- NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_assertion wasDerivedFrom befree-2016 NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_provenance.
- NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_assertion wasGeneratedBy ECO_0000203 NP715608.RAX7tB4QsC_C4chouad20gR39G_FKzzmz76P6cYGsC-ww130_provenance.